MARKET

MXCT

MXCT

Maxcyte
NASDAQ
0.6836
-0.0332
-4.63%
After Hours: 0.6745 -0.0091 -1.33% 16:16 03/27 EDT
OPEN
0.6981
PREV CLOSE
0.7168
HIGH
0.7247
LOW
0.6606
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
3.170
52 WEEK LOW
0.6434
MARKET CAP
72.92M
P/E (TTM)
-1.6303
1D
5D
1M
3M
1Y
5Y
1D
MaxCyte Is Maintained at Buy by Craig-Hallum
Dow Jones · 2d ago
MaxCyte Price Target Cut to $5.00/Share From $7.00 by Craig-Hallum
Dow Jones · 2d ago
Craig-Hallum Maintains Buy on MaxCyte, Lowers Price Target to $5
Benzinga · 2d ago
MaxCyte price target lowered to $5 from $7 at Craig-Hallum
TipRanks · 2d ago
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook
Seeking Alpha · 2d ago
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
The Motley Fool · 2d ago
MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 2d ago
MaxCyte Reports Lower 2025 Revenue, Provides 2026 Outlook
TipRanks · 2d ago
More
About MXCT
MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support cell-based research and development. It has developed and commercialized its proprietary Flow Electroporation technology, which is used by biopharmaceutical companies in the complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address this rapidly expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes four instruments, which are known as the ATx, STx, GTx and VLx, as well as a portfolio of proprietary related disposables and consumables.

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.